October 5 | 9:30AM EDT
Moderator: Roger Gunn, Ph.D. | Chief Scientific Officer, Invicro
Panelists: John Beaver, Ph.D. |Vice President & Head of Biomarkers, Imaging, Bioanalytical Sciences, Translational Pathology and Diagnostic Pathways, Biogen
Susan De Santi, Ph.D. | Executive Director, Global Medical Affairs, Patient Journey, Neurology Business Group, Eisai, Inc
Gregory Klein, Ph.D. | Senior Principal Scientist & Head of Clinical Imaging, Neuroscience & Rare Disease Biomarkers & Translational Technology, Roche
Kenneth Marek, Ph.D. | Distinguished Scientist, Invicro
October 6 | 11:00AM EDT
Moderator: Kenneth Bloom, M.D., FCAP | Chief Medical Officer, Advanced Pathology and Genomic Services, Invicro
Panelists: Eslie Dennis, M.D., MBChB, FCP(SA) | Senior Vice President, Chief Medical Officer and Head of North America Medical Affairs, Kyowa Kirin, Inc.
Michael D. Feldman, M.D., Ph.D. | Professor, Pathology & Laboratory Medicine, Vice Chair of Clinical Services, Medical Director Pathology Informatics, Director Tumor Tissue Bank, University of Pennsylvania School of Medicine
Phillip Kuo, M.D., Ph.D. | Senior Medical Director, Invicro